• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中浆患者接受半剂量光动力疗法后的长期外层视网膜改变。

Long term outer retinal changes in central serous chorioretinopathy submitted to half-dose photodynamic therapy.

机构信息

Department of Ophthalmology, Centro Hospitalar Universitário de São João, Porto, Portugal.

Department of Ophthalmology, Centro Hospitalar Universitário de São João, Porto, Portugal; Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal.

出版信息

Photodiagnosis Photodyn Ther. 2021 Jun;34:102235. doi: 10.1016/j.pdpdt.2021.102235. Epub 2021 Feb 22.

DOI:10.1016/j.pdpdt.2021.102235
PMID:33631379
Abstract

PURPOSE

To evaluate long-term changes in the foveal and parafoveal outer retina after half-dose photodynamic therapy (HD-PDT) in central serous chorioretinopathy (CSC).

METHODS

Retrospective study including CSC patients submitted to HD-PDT. Best corrected visual acuity (BCVA) was evaluated. Spectral-domain optical coherence tomography automatic segmentation algorithm was used and data on retinal, inner retinal, outer retinal and outer nuclear layers (ONL) in both foveal 1 mm (C) and parafoveal 3 mm ETDRS circles for the superior, nasal, inferior and temporal sectors, were obtained at baseline and 3, 12 and 24 months post-treatment. Subfoveal choroidal thickness, photoreceptors' outer segment thickness, subretinal fluid (SRF) height and width were also measured.

RESULTS

Twenty-one eyes of 15 patients were included. At baseline, the mean ONL thickness in the foveal area was significantly thinner in affected eyes compared to their fellow unaffected ones (55,50 ± 32,75 μm vs 93,00 ± 17,0 μm; p = 0,011), and was negatively correlated to logMAR BCVA (R=-0,601, p = 0,008) ONL thickness increased by 10,94 ± 11,88 μm at 24 months in the foveal area, and all the parafoveal sectors presented a similar increase. Baseline SRF width was significantly correlated with baseline BCVA (R1 = 0,483, p = 0,036), and with ONL thickness in all sectors.

CONCLUSION

In our study we found a significant long-term increase in foveal and parafoveal ONL thickness in CSC after HD-PDT, suggesting that this seems to be a safe treatment for the outer retina. This is the first study mapping the outer retinal changes in the macular area to 24 months follow up.

摘要

目的

评估半剂量光动力疗法(HD-PDT)治疗中心性浆液性脉络膜视网膜病变(CSC)后黄斑及旁中心凹外视网膜的长期变化。

方法

回顾性研究纳入了接受 HD-PDT 的 CSC 患者。评估最佳矫正视力(BCVA)。采用频域光相干断层扫描自动分割算法,获得治疗前及治疗后 3、12 和 24 个月时黄斑中心 1mm(C)和旁中心 3mm ETDRS 环的视网膜、内视网膜、外视网膜和外核层(ONL)的视网膜、内视网膜、外视网膜和外核层(ONL)的数据,并分别测量黄斑下脉络膜厚度、光感受器外节厚度、视网膜下液(SRF)高度和宽度。

结果

共纳入 15 例患者的 21 只眼。治疗前,受累眼黄斑区 ONL 厚度明显薄于对侧眼(55.50 ± 32.75μm vs 93.00 ± 17.0μm;p = 0.011),且与 logMAR BCVA 呈负相关(R=-0.601,p = 0.008)。治疗后 24 个月时,黄斑区 ONL 厚度增加 10.94 ± 11.88μm,所有旁中心凹区均有类似增加。治疗前 SRF 宽度与治疗前 BCVA 呈显著正相关(R1 = 0.483,p = 0.036),与各象限 ONL 厚度均呈显著正相关。

结论

我们的研究发现,CSC 患者接受 HD-PDT 治疗后黄斑及旁中心凹外视网膜的 ONL 厚度有显著的长期增加,提示这种治疗方法似乎对外视网膜是安全的。这是首次对黄斑区外视网膜进行长达 24 个月随访的研究。

相似文献

1
Long term outer retinal changes in central serous chorioretinopathy submitted to half-dose photodynamic therapy.中浆患者接受半剂量光动力疗法后的长期外层视网膜改变。
Photodiagnosis Photodyn Ther. 2021 Jun;34:102235. doi: 10.1016/j.pdpdt.2021.102235. Epub 2021 Feb 22.
2
Microstructural changes after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变患者半剂量光动力疗法后的微观结构变化。
Photodiagnosis Photodyn Ther. 2021 Sep;35:102347. doi: 10.1016/j.pdpdt.2021.102347. Epub 2021 May 24.
3
Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变:视力预后的易感因素
Semin Ophthalmol. 2018;33(5):690-699. doi: 10.1080/08820538.2017.1416414. Epub 2017 Dec 18.
4
Threshold thickness of foveal outer nuclear layer associated with outcomes of photodynamic therapy in central serous chorioretinopathy.与中心性浆液性脉络膜视网膜病变光动力疗法结果相关的黄斑外层核层厚度阈值。
Eye (Lond). 2022 Oct;36(10):1884-1889. doi: 10.1038/s41433-021-01762-0. Epub 2021 Sep 3.
5
Foveal and Extrafoveal Effects of Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Cohort Study.半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的中心凹和周边区效果:一项队列研究。
Semin Ophthalmol. 2022 Feb 17;37(2):153-157. doi: 10.1080/08820538.2021.1931357. Epub 2021 May 23.
6
One-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis.中心性浆液性脉络膜视网膜病变低强度光动力疗法治疗 1 年的结果:外核层厚度与视力预后相关。
Graefes Arch Clin Exp Ophthalmol. 2013 Aug;251(8):1909-17. doi: 10.1007/s00417-013-2289-4. Epub 2013 Mar 2.
7
Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变光动力疗法后的长期脉络膜视网膜改变。
Graefes Arch Clin Exp Ophthalmol. 2013 Jul;251(7):1697-705. doi: 10.1007/s00417-013-2270-2. Epub 2013 Feb 7.
8
[Observation on long-term efficacy of half-dose photodynamic therapy with chronic central serous chorioretinopathy using optical coherence tomography].[应用光学相干断层扫描观察半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的长期疗效]
Zhonghua Yan Ke Za Zhi. 2016 May;52(5):328-34. doi: 10.3760/cma.j.issn.0412-4081.2016.05.004.
9
The relationship between foveal outer nuclear layer thickness in the active and resolved phases of central serous chorioretinopathy treated with half-dose photodynamic therapy.半剂量光动力疗法治疗中心性浆液性脉络膜视网膜病变活动期与缓解期的黄斑外核层厚度之间的关系。
BMC Ophthalmol. 2019 Mar 29;19(1):84. doi: 10.1186/s12886-019-1089-y.
10
Relationship between photoreceptor layer changes before half-dose photodynamic therapy and functional and anatomic outcomes in central serous chorioretinopathy.半剂量光动力疗法前光感受器层变化与中心性浆液性脉络膜视网膜病变功能和解剖结局的关系。
Eye (Lond). 2021 Mar;35(3):1002-1010. doi: 10.1038/s41433-020-1018-6. Epub 2020 Jun 16.

引用本文的文献

1
Predictive Factors for Morphological and Functional Improvements in Long-Lasting Central Serous Chorioretinopathy Treated with Photodynamic Therapy.光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变形态学和功能改善的预测因素
Biomedicines. 2025 Apr 11;13(4):944. doi: 10.3390/biomedicines13040944.
2
New high-resolution prototype versus standard spectralis optical coherence tomography in patients with central serous chorioretinopathy.新型高分辨率原型与标准Spectralis光学相干断层扫描技术在中心性浆液性脉络膜视网膜病变患者中的应用比较
Int J Retina Vitreous. 2024 Oct 16;10(1):78. doi: 10.1186/s40942-024-00598-6.
3
Changes in the outer nuclear layer and choroidal vascularity during the manifest and quiescent phases of acute central serous chorioretinopathy.
急性中心性浆液性脉络膜视网膜病变活动期和静止期的外核层和脉络膜血管变化。
Sci Rep. 2024 Jul 11;14(1):16057. doi: 10.1038/s41598-024-67012-x.
4
Morphological integrity of the outer retinal layers and visual prognosis in chronic central serous chorioretinopathy after half-dose photodynamic therapy: a qualitative SD-OCT analysis.半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变后外层视网膜形态完整性与视力预后的定性 SD-OCT 分析。
Lasers Med Sci. 2022 Dec 21;38(1):9. doi: 10.1007/s10103-022-03676-z.
5
Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy.中心性浆液性脉络膜视网膜病变病程中的神经节细胞丢失
Ophthalmol Ther. 2023 Feb;12(1):517-533. doi: 10.1007/s40123-022-00625-5. Epub 2022 Dec 12.